269 related articles for article (PubMed ID: 28453518)
1. LC-MS-MS quantitative analysis reveals the association between FTO and DNA methylation.
Zhu Y; Zhou G; Yu X; Xu Q; Wang K; Xie D; Yang Q; Wang L
PLoS One; 2017; 12(4):e0175849. PubMed ID: 28453518
[TBL] [Abstract][Full Text] [Related]
2. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.
Kang H; Zhang Z; Yu L; Li Y; Liang M; Zhou L
J Cell Biochem; 2018 Jul; 119(7):5676-5685. PubMed ID: 29384213
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
[TBL] [Abstract][Full Text] [Related]
4. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO.
Jia G; Yang CG; Yang S; Jian X; Yi C; Zhou Z; He C
FEBS Lett; 2008 Oct; 582(23-24):3313-9. PubMed ID: 18775698
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
6. Distinct RNA
Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
[TBL] [Abstract][Full Text] [Related]
7. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
Relier S; Rivals E; David A
RNA Biol; 2022; 19(1):132-142. PubMed ID: 35067178
[TBL] [Abstract][Full Text] [Related]
8. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of FTO (fat mass and obesity-associated) reveals that it is unlikely to function as a sensor for 2-oxoglutarate.
Ma M; Harding HP; O'Rahilly S; Ron D; Yeo GS
Biochem J; 2012 Jun; 444(2):183-7. PubMed ID: 22435707
[TBL] [Abstract][Full Text] [Related]
10. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
11. An α-ketoglutarate conformational switch controls iron accessibility, activation, and substrate selection of the human FTO protein.
Burns D; Khatiwada B; Singh A; Purslow JA; Potoyan DA; Venditti V
Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2404457121. PubMed ID: 38865275
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.
Du YD; Guo WY; Han CH; Wang Y; Chen XS; Li DW; Liu JL; Zhang M; Zhu N; Wang X
Cell Death Dis; 2021 May; 12(5):442. PubMed ID: 33947842
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
14. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing.
Bartosovic M; Molares HC; Gregorova P; Hrossova D; Kudla G; Vanacova S
Nucleic Acids Res; 2017 Nov; 45(19):11356-11370. PubMed ID: 28977517
[TBL] [Abstract][Full Text] [Related]
16. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
[TBL] [Abstract][Full Text] [Related]
18. Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner.
Wu Y; Li J; Li C; Lu S; Wei X; Li Y; Xia W; Qian C; Wang Z; Liu M; Gu Y; Huang B; Tan Y; Hu Z
J Biol Chem; 2023 Jun; 299(6):104783. PubMed ID: 37146971
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.
Jia G; Fu Y; Zhao X; Dai Q; Zheng G; Yang Y; Yi C; Lindahl T; Pan T; Yang YG; He C
Nat Chem Biol; 2011 Oct; 7(12):885-7. PubMed ID: 22002720
[TBL] [Abstract][Full Text] [Related]
20. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
